Verified factor-similar pair

FNY vs PRN

These two ETFs meet the same FF6 US comparison criteria: US-listed equity ETFs, the same USD model basis, at least one material non-market factor, and 100% overlap in statistically significant material factor exposure.

SMB UMD
Similarity score
83
Verified similar

The score combines exposure-level distance, factor-vector shape, market-beta closeness, and a small backtested relative-Sharpe term.

Quick Read

  • PRN has the higher backtested relative Sharpe (1.155 vs 0.943).
  • PRN has the lower published fee (0.69% vs 0.73%).
  • FNY is cheaper on dividend valuation (128 vs 225, where 100 is each fund's historical median).
  • FNY has the stronger regression fit (adjusted R-squared 0.921 vs 0.845).

These are screening signals, not a complete review of portfolio construction, turnover, taxes, or trading quality.

FNY

First Trust Mid Cap Growth AlphaDEX Fund
SMB UMD
Adj. R2
0.921
Rel. Sharpe
0.943
Mkt beta
1.07
AUM
US$486M
MER
0.73%
Valuation
128

PRN

Invesco Dorsey Wright Industrials Momentum ETF
SMB UMD
Adj. R2
0.845
Rel. Sharpe
1.155
Mkt beta
1.14
AUM
US$363M
MER
0.69%
Valuation
225

Factor Exposure Match

Blue bars compare raw factor beta magnitude. Green bars compare absolute t-stat strength. Dim bars indicate the t-stat is below 1.96.

SMB
FNY
+0.59
|t|
+11.7
PRN
+0.52
|t|
+7.5
diff +0.07
HML
FNY
-0.09
|t|
-1.8
PRN
-0.11
|t|
-1.7
diff +0.03
RMW
FNY
-0.04
|t|
-0.7
PRN
-0.04
|t|
-0.5
diff +0.00
CMA
FNY
-0.03
|t|
-0.4
PRN
+0.06
|t|
+0.6
diff -0.09
UMD
FNY
+0.25
|t|
+7.1
PRN
+0.14
|t|
+3.6
diff +0.10

Why This Pair Matches

Exposure level
81
Exposure shape
99
Mkt beta diff
0.07
Rel. Sharpe diff
0.212

This comparison focuses on measured factor exposure. It does not compare holdings methodology, turnover, tax handling, or issuer process. Backtested relative Sharpe is a secondary signal rather than a stand-alone forecast. See methodology.

FNY fund page PRN fund page US ETF Leaders US Universe
Important context

VerifiedBeta publishes educational ETF research, not personalized investment advice, portfolio management, or security recommendations. Funds that screen well here can still be unsuitable for your objectives, taxes, liquidity needs, or constraints. Review fund documents, methodology assumptions, and your own circumstances before acting. See the full disclaimer.